Skip to main content

Table 1 Comparison between uncomplicated and complicated groups

From: Point-of-care urine Gram stain led to narrower-spectrum antimicrobial selection for febrile urinary tract infection in adolescents and adults

Ā 

Uncomplicated group (Nā€‰=ā€‰48)

Complicated group (Nā€‰=ā€‰218)

p value

Median age (IQR)

41 (31ā€“60)

80 (69ā€“88)

ā€‰<ā€‰0.0001*

Female sex

48 (100%)

139 (63.8%)

ā€‰<ā€‰0.001*

Performance status

Ā Ā Ā 

Ā Ā 0ā€“2

48 (100%)

144 (66.0%)

ā€‰<ā€‰0.001*

Ā Ā 3ā€“4 (in bed more than 50%)

0

74 (33.9%)

ā€‰<ā€‰0.001*

Living place before admission

Ā Ā Ā 

Ā Ā Home

48 (100%)

156 (71.6%)

ā€‰<ā€‰0.001*

Ā Ā Nursing facility or hospital

0

62 (28.4%)

ā€‰<ā€‰0.001*

Symptom duration days (IQR)

2 (1ā€“3)

1 (0ā€“2)

0.0065*

Bladder inflammatory symptoms

36 (75.0%)

73 (33.5%)

ā€‰<ā€‰0.001*

Shaking chills

35 (72.9%)

85 (39.0%)

ā€‰<ā€‰0.001*

Physical examinations

Ā Ā Ā 

Ā Ā CVA tenderness

38 (79.2%)

46 (21.1%)

ā€‰<ā€‰0.001*

Ā Ā Bimanual palpation

38 (79.2%)

48 (22.0%)

ā€‰<ā€‰0.001*

Ā Ā Prostate tenderness

0

20 (27.8%)

0.029*

Catecholamine support needed

1 (2.1%)

7 (3.2%)

1.000

Urinalysis

Ā Ā Ā 

Ā Ā Pyuria

46 (95.8%)

215 (99.1%)

0.15

Ā Ā Bacteriuria

47 (97.9%)

212 (97.7%)

0.70

Urine PCGS

Ā Ā Ā 

Ā Ā Pyuria

48 (100%)

215 (98.6%)

0.55

Ā Ā Bacteriuria

45 (93.8%)

213 (97.7%)

0.16

Urine culture results

Escherichia coli 44

Escherichia coli 157

Ā 
Ā 

Enterobacter aerogenes 3

Klebsiella spp. 24

Ā 
Ā 

Streptococcus spp. 2

Pseudomonas aeruginosa 12

Ā 
Ā 

Nonpathogenic 1

Citrobacter spp. 11

Ā 
Ā Ā 

Streptococcus spp. 11

Ā 
Ā Ā 

Proteus mirabilis 9

Ā 
Ā Ā 

Enterococcus faecalis 6

Ā 
Ā Ā 

Morganella morganeii 6

Ā 
Ā Ā 

Serratia marcescens 4

Ā 
Ā Ā 

Others 10

Ā 
Ā Ā 

Nonpathogenic 11

Ā 
Ā Ā 

Negative 1

Ā 

Blood culture positivity

8 (16.7%)

67 (30.7%)

0.053

Blood culture results

Escherichia coli 8

Escherichia coli 57

Ā 
Ā Ā 

Klebsiella spp. 5

Ā 
Ā Ā 

Enterococcus spp. 2

Ā 
Ā Ā 

Others 6

Ā 

Antimicrobial resistance

1 (2.1%)

32 (14.7%)

0.014*

Initial antibiotics

Ā Ā Ā 

Ā Ā Based on PCGS

45 (93.8%)

184 (84.4%)

0.064

Ā Ā Based on previous cultures

1 (2.1%)

31 (14.2%)

0.010*

Ā Ā Empirical treatment

2 (4.1%)

3 (1.4%)

0.22

Death

0

2 (0.9%)

0.51

  1. CVA costovertebral angle
  2. IQR interquartile range
  3. PCGS point-of-care Gram stain
  4. *pā€‰<ā€‰0.05